📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEY. (2024)

First Author: Nangaku M

Attributed to: Randomised trials in cardiovascular and metabolic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10157-024-02489-4

PubMed Identifier: 38643286

Publication URI: http://europepmc.org/abstract/MED/38643286

Type: Journal Article/Review

Volume: 28

Parent Publication: Clinical and experimental nephrology

Issue: 6

ISSN: 1342-1751